Hematologic Neoplasms: all 1,494 studies
Page 8 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Laser vs Ozone Therapy for Oral Mucositis in Cancer PatientsCompletedNCT07069153Not applicable
- Investigation of the Effects of Prehabilitation Education Delivered Through a Mobile Compatible Website on Quality of Life and Symptoms in Patients Undergoing Hematopoietic Stem Cell TransplantationActive, not recruitingNCT07066592Not applicable
- Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From ChinaCompletedNCT06900114
- Addressing Financial Hardship in Adolescent and Young Adult Cancer SurvivorsCompletedNCT06881108
- A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersTerminatedNCT06870487Phase 1
- Precise Design of Cell Therapy for Relapsed and Refractory Hematological TumorsActive, not recruitingNCT06849921Not applicable
- Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patients With Febrile NeutropeniaActive, not recruitingNCT06787326
- CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I TrialActive, not recruitingNCT06765876Early Phase 1
- Comparison of Hemanext ONE® System and Conventional Red Blood Cell TransfusionActive, not recruitingNCT06685848Not applicable
- A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic MalignanciesActive, not recruitingNCT06645886Phase 1
- Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.Active, not recruitingNCT06645132Not applicable
- A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)CompletedNCT06586671Phase 1
- Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological MalignanciesActive, not recruitingNCT06584955Not applicable
- Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
- FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-MyocarditisTerminatedNCT06566209
- Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)CompletedNCT06559579
- MyeloGen: Germline Testing for Predisposition to Myeloid MalignanciesWithdrawnNCT06543511Not applicable
- Interpretability of the Quantra® Viscoelastic Test in Patients with Haematological Malignancies with Profound Thrombocytopenia Below 50x10 G/L.CompletedNCT06455553Not applicable
- CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCTActive, not recruitingNCT06449586Phase 3
- Outcomes of Critically Ill Patients With Hematologic MalignanciesCompletedNCT06410066
- Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell TransplantationCompletedNCT06395220
- A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)WithdrawnNCT06395090Phase 1/2
- CD155 Expression in Acute Myeloid LeukemiaCompletedNCT06369662
- Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.Active, not recruitingNCT06359002Phase 1
- Study of AZD9829 in CD123+ Hematological MalignanciesCompletedNCT06179511Phase 1/2
- Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive InterventionCompletedNCT06168825
- A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT SurvivorsActive, not recruitingNCT06153797Not applicable
- ATG Plus Low-dose PT-Cy for GVHD PreventionTerminatedNCT06108739Phase 3
- A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient ChemotherapyActive, not recruitingNCT06106360
- Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES StudyActive, not recruitingNCT06102876
- Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell TransplantationTerminatedNCT06102213Phase 2
- An Educational Intervention on Provider Knowledge for the Support of Cancer SurvivorsCompletedNCT06062901Not applicable
- Research-Action in Hematology From Hospitalization to HomeCompletedNCT06053918
- A Phase I Study of BR108 in Hematological MalignanciesTerminatedNCT06018506Phase 1
- Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell TransplantationCompletedNCT06010017Not applicable
- Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyCompletedNCT05972577Not applicable
- TCRαβ/CD19 Depletion of Stem Cell Grafts for TransplantWithdrawnNCT05968170Not applicable
- A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological MalignanciesActive, not recruitingNCT05944978Phase 1/2
- RD13-02 for Patients With r/r CD7+ T Cell Hematologic MalignanciesCompletedNCT05923541Early Phase 1
- Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)CompletedNCT05907603Early Phase 1
- RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBLCompletedNCT05902845Early Phase 1
- Retrospective Registry Study of Patients With Cancer Treated With High-dose MethotrexateStatus unknownNCT05899751
- Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological MalignanciesCompletedNCT05895994Early Phase 1
- The Effect of Music Therapy on Comfort, Pain and AnxietyCompletedNCT05895357Not applicable
- Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell TransplantationActive, not recruitingNCT05873205Phase 2
- Exploratory Study of IMM01 for Injection in the Treatment of Refractory or Recurrent Hematologic MalignancyTerminatedNCT05860075Phase 1
- Evaluation of ClearLLab LS Screening PanelCompletedNCT05819762
- The Effect of Lavender Oil on Fatigue and Sleep QualityStatus unknownNCT05808296Not applicable
- Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )CompletedNCT05790538
- Immunity to Infection in Healthy Participants and Participants With CancerActive, not recruitingNCT05787964
- A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic TumorsStatus unknownNCT05784870Phase 3
- Telerehabilitation in Hemato-oncological SurvivorsCompletedNCT05779605Not applicable
- Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCTStatus unknownNCT05759975Not applicable
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesActive, not recruitingNCT05753501Phase 1
- HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWithdrawnNCT05740449Phase 1/2
- Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral CapsuleActive, not recruitingNCT05716919Phase 1
- CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBLCompletedNCT05716113Early Phase 1
- Intervention for Fatigue in HCT RecipientsCompletedNCT05715047Not applicable
- Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell TransplantActive, not recruitingNCT05709912Not applicable
- Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer PatientsStatus unknownNCT05709522
- Improving Patient Experience: BMBACompletedNCT05690230Not applicable
- Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic TumorsActive, not recruitingNCT05683353
- Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic MalignanciesStatus unknownNCT05672420Phase 1/2
- A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic MalignanciesCompletedNCT05665530Phase 1
- Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint InhibitorsWithdrawnNCT05660421Phase 2
- A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic MalignanciesStatus unknownNCT05654038Phase 1/2
- CAR-NK Targeted CD19 for r/r B-cell MalignanciesStatus unknownNCT05645601Phase 1
- Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up CareCompletedNCT05641961Not applicable
- QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient ManagementStatus unknownNCT05626764
- Financial Navigation Study Among Young Adult Blood Cancer SurvivorsCompletedNCT05620979Not applicable
- Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor SubjectsStatus unknownNCT05610202Phase 1
- Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic MalignanciesTerminatedNCT05609942Phase 1
- Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell TransplantationStatus unknownNCT05609227Not applicable
- Mindfulness-based Virtual Reality InterventionStatus unknownNCT05602051Not applicable
- Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic ImpairmentCompletedNCT05599932Phase 1
- Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic MalignanciesWithdrawnNCT05570188Phase 1/2
- Home Transfusion for HEMECompletedNCT05509439Not applicable
- Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic PainCompletedNCT05506982Phase 1
- Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation OncologyActive, not recruitingNCT05496972
- Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCTActive, not recruitingNCT05493800Phase 2
- Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological TumorsStatus unknownNCT05489276Phase 1
- DxFLEX 10C Clinical StudyCompletedNCT05467449
- Coverage and Cost-of-Care (CC) Links- Financial Navigation ProgramCompletedNCT05465577Not applicable
- Central Venous Catheter-related Complications in Patients Under Anticancer TreatmentStatus unknownNCT05455866
- CD7 CAR-T for Patients With r/r CD7+ Hematologic MalignanciesCompletedNCT05454241Phase 2
- Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.CompletedNCT05450367
- Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid LeukemiaStatus unknownNCT05445765Phase 1
- Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)Status unknownNCT05443854Phase 3
- A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological MalignanciesActive, not recruitingNCT05428969Phase 1/2
- Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans SyndromeStatus unknownNCT05413356Phase 2
- Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerSuspendedNCT05400122Phase 1
- Mechanisms of Disease R/R in CAR-T for Hematologic MalignanciesCompletedNCT05397132
- Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective StudyActive, not recruitingNCT05396157
- Study Evaluating Food Effect and QTc in Patients With Advanced MalignanciesCompletedNCT05391022Phase 1
- CAR-T Cell Therapy in Patients With Hematological MalignanciesCompletedNCT05390671
- Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic TherapyStatus unknownNCT05364359Not applicable
- An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT StudyActive, not recruitingNCT05364086
- Vincristine Pharmacokinetics in InfantsActive, not recruitingNCT05359237
- Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.CompletedNCT05352789
- First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic MalignanciesTerminatedNCT05348889Phase 1/2